Terms: = Breast cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
22 results:
1. Dulaglutide as a demethylating agent to improve the outcome of breast cancer.
Tatsch JM; Furman DP; Nobre RM; Wurzer KM; da Silva LC; Picheth GF; Ramos EA; Acco A; Klassen G
Epigenomics; 2023 Dec; 15(24):1309-1322. PubMed ID: 38174426
[No Abstract] [Full Text] [Related]
2. Screening of BRCA1 (c.5177_5180delGAAA rs80357867 and c.4986+6T>C rs80358086) and the BRCA2 (c.6445_6446delAT rs80359592) Genes for breast cancer Prevention in Burkina Faso.
Kiendrebeogo IT; Zoure AA; Zongo FI; Ouedraogo SY; Sawadogo AY; Amegnona J; Sombie HK; Bazie JTVE; Sorgho PA; Yonli AT; Ouedraogo MNL; Obiri-Yeboah D; Zongo N; Bambara HA; Simpore J
Ethiop J Health Sci; 2022 Jul; 32(4):699-708. PubMed ID: 35950060
[TBL] [Abstract] [Full Text] [Related]
3. Impact of diabetes on promoting the growth of breast cancer.
Chou PC; Choi HH; Huang Y; Fuentes-Mattei E; Velazquez-Torres G; Zhang F; Phan L; Lee J; Shi Y; Bankson JA; Wu Y; Wang H; Zhao R; Yeung SJ; Lee MH
Cancer Commun (Lond); 2021 May; 41(5):414-431. PubMed ID: 33609419
[TBL] [Abstract] [Full Text] [Related]
4. The rs2234694 and 50 bp Insertion/Deletion polymorphisms of the SOD1 gene are associated with breast cancer risk in a Mexican population.
Gallegos-Arreola MP; Ramírez-Hernández MA; Figuera LE; Zúñiga-González GM; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8017-8027. PubMed ID: 32767328
[TBL] [Abstract] [Full Text] [Related]
5. Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
Davies G; Lobanova L; Dawicki W; Groot G; Gordon JR; Bowen M; Harkness T; Arnason T
PLoS One; 2017; 12(12):e0187191. PubMed ID: 29211738
[TBL] [Abstract] [Full Text] [Related]
6. Diabetes and Overall Survival among breast cancer Patients in the U.S. Military Health System.
Shao S; Gill AA; Zahm SH; Jatoi I; Shriver CD; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):50-57. PubMed ID: 29097445
[No Abstract] [Full Text] [Related]
7. Metformin Has Positive Therapeutic Effects in Colon cancer and Lung cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract] [Full Text] [Related]
8. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
[TBL] [Abstract] [Full Text] [Related]
9. Technical Note: Validation of two methods to determine contact area between breast and compression paddle in mammography.
Branderhorst W; de Groot JE; van Lier MGJTB; Highnam RP; den Heeten GJ; Grimbergen CA
Med Phys; 2017 Aug; 44(8):4040-4044. PubMed ID: 28569996
[TBL] [Abstract] [Full Text] [Related]
10. Metformin Has a Positive Therapeutic Effect on Prostate cancer in Patients With Type 2 Diabetes Mellitus.
Chong RW; Vasudevan V; Zuber J; Solomon SS
Am J Med Sci; 2016 Apr; 351(4):416-9. PubMed ID: 27079349
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence of cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
Jalil NA; Zin AA; Othman NH
Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
[TBL] [Abstract] [Full Text] [Related]
12. Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity.
Sun F; Qi X; Geng C; Li X
Am J Med Sci; 2015 May; 349(5):406-12. PubMed ID: 25723884
[TBL] [Abstract] [Full Text] [Related]
13. Mammographic compression after breast conserving therapy: controlling pressure instead of force.
de Groot JE; Broeders MJ; Branderhorst W; den Heeten GJ; Grimbergen CA
Med Phys; 2014 Feb; 41(2):023501. PubMed ID: 24506652
[TBL] [Abstract] [Full Text] [Related]
14. [Underestimation of papillary breast lesions at ultrasound-guided breast biopsy].
Zhou JY; Tang J; Luo YK; Fu S; Song Q; Xu QH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Dec; 35(6):662-6. PubMed ID: 24382246
[TBL] [Abstract] [Full Text] [Related]
15. Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.
Berstein LM; Iyevleva AG; Vasilyev D; Poroshina TE; Imyanitov EN
Cell Cycle; 2013 Dec; 12(23):3681-8. PubMed ID: 24145224
[TBL] [Abstract] [Full Text] [Related]
16. cancer detection rates following enrolment in a disease management programme for type 2 diabetes.
Geier AS; Wellmann J; Wellmann I; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetologia; 2013 Sep; 56(9):1944-8. PubMed ID: 23722623
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
[TBL] [Abstract] [Full Text] [Related]
18. Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin.
Tomas NM; Masur K; Piecha JC; Niggemann B; Zänker KS
BMC Res Notes; 2012 Jul; 5():214. PubMed ID: 22554284
[TBL] [Abstract] [Full Text] [Related]
19. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
[TBL] [Abstract] [Full Text] [Related]
20. Influence of diabetes mellitus type 2 and prolonged estrogen exposure on risk of breast cancer among women in Armenia.
Khachatryan L; Scharpf R; Kagan S
Health Care Women Int; 2011 Nov; 32(11):953-71. PubMed ID: 21978143
[TBL] [Abstract] [Full Text] [Related]
[Next]
